摘要
干扰素(Interferon,IFN)是细胞对病毒感染和各种合成及生物诱生作用反应而分泌的一类蛋白质,具有抗病毒、抗增殖、诱导分化及调节免疫等作用。作为病毒性疾病及肿瘤有效生物体药物已被广泛应用于治疗多种病毒性疾病,如:病毒性乙肝、丙肝、带状疱疹、尖锐湿疣以及治疗某些肿瘤,
出处
《基层医学论坛》
2010年第22期745-746,共2页
The Medical Forum
参考文献15
-
1Poynard T,Leroy V,Cohard M,et al.Meta-analysis of interferon randomized trials in treatment of viral hepatitis C:effects of dose and duratiou[J].Hepatology,1996,24(8):778.
-
2Russello M.Recombinant interferon alpha therapy in elderly patients with chronic hepatitis C without cirrhosis[J].Arch Gerontol Geriatr,1996,55(4):321-325.
-
3Conlon KC.Exacerbation of Symptoms autoimmune disease in patient receiving alpha-interferon therapy[J].Cancer,1990,65 (25):2237-2242.
-
4Shrestha R,Mekinley C,Bilir BM,et al.Possible idiopathic thromboey-topenic purpura associated with natural alpha interferon therapy for chronic hepatitis C infection[J].Am J Gastroenterol,1995,90 (12):1146.
-
5Benjarrun S,Baln B J,Dodsworth H.Severe bleeding associated with worsening thrombocytopenia following alpha interferon therapy for autoimmune thrombocytopenic purpura[J].Clin Res,1992,40(9):840.
-
6Smith MJ,Khayci D.Residual acute confusional and hallucinatory syndromes induced by lnterleukin-2/a-interferon treatment[J].Psyehoucology,1992,1 (2):115-118.
-
7Martin H,genner.Nouropsychiatric symptoms during treatment with inter liukin-2 and interferou[J].Lancet,1993,341 (8841):372.
-
8Lombardini F.Psoriatic arthritis with spinal involvement in a patient receiving alpha-intederon for chronic hepatitis C[J].Acand J Rheomatol,1997,26(1):58-60.
-
9Watanake U.The risk factor for development of thyroid disease,during interferon therapy for chronic hepatitis C[J].Gastroenterol,1994,89(3):399-403.
-
10Lisker-Melman.Developmeut of thyroid disease during therapy of chronic Vital hepatitis with interferon alpha[J].Gastroenterology,1992,102(6):2155-2160.
二级参考文献1
-
1陈捷.干扰素结膜下注射致过敏性休克1例[J]临床眼科杂志,1998(05).
同被引文献37
-
1李柳萍,杨胥微,王妍.干扰素(Ⅰ型α、β,Ⅱ型γ)的分子结构和生物活性的对应关系及其临床应用[J].微生物学免疫学进展,2011,39(2):65-71. 被引量:4
-
2魏荣堂,魏永利.干扰素的不良反应[J].实用医技杂志,2005,12(08B):2310-2312. 被引量:12
-
3戴亦晖,王小虹.干扰素诱发急性左心功能不全1例报告[J].中国实用乡村医生杂志,2007,14(7):60-60. 被引量:1
-
4garkwooa JM,Bender C,Agatwala S,et al.Mechanisms and management of toxicities associated with high-dose inter-feronα-2b therapy[J].J Clin Oncol,2002,20(17):3703-3718.
-
5Taylor JL,Grossberg SEThe effects of interferon-αon the prod-uction and action ofother cytokines[J].Semin Oncol,1998,25(1Suppl 1):23-29.
-
6Plata-Salamán CR.Cytokines and anorexia:a brief overview[J].Semin Oncol,1998,25(1 Suppl 1):64-72.
-
7Ghany MG, Strader DB, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C: all update. Hepatology, 2009, 49: 1335-1374.
-
8Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa 2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med, 2002,347 : 975-982.
-
9Kirkwood JM, Bender C, Agarwala S, et al. Mechanisms and management of toxicities associaited with high-dose interferon a-2b therapy. J Clin Oncol,2002,20:3703- 3718.
-
10Russo MW, Fried MW. Side effects of therapy for chronic hepatitis C. Gastroenterology, 2(1(}3, 124 1711-1719.
引证文献3
-
1余世敏,戴丹,余海静.六味地黄丸预防干扰素副反应的临床观察[J].中医临床研究,2010,2(22):20-21. 被引量:1
-
2郑雯,马慧群.干扰素的不良反应及处理[J].中国医学文摘(皮肤科学),2014,31(4):217-220. 被引量:9
-
3陈吐芬,周勤,江晓静.干扰素联合利巴韦林治疗丙型肝炎不良反应的发病机制及处理[J].肝脏,2014,19(7):543-548. 被引量:7
二级引证文献16
-
1于梦琦,张婉乔,王成祥,秦楠坤,赖晓静,杨飞,李双双,马群.基于Meta分析的热毒宁注射液联合利巴韦林治疗小儿手足口病有效性和安全性评价[J].药物流行病学杂志,2020,29(2):97-104. 被引量:15
-
2赵静.整体护理对干扰素治疗肝炎致精神及神经系统不良反应的效果观察[J].实用临床医药杂志,2015,19(18):52-54. 被引量:2
-
3王晶波,赵秀红,崔师玉,李晓迎.干扰素治疗乙型和丙型肝炎致指(趾)甲不良反应4例报告[J].临床肝胆病杂志,2015,31(9):1485-1487. 被引量:1
-
4郑拓,吴长德.犬IL-29基因的克隆与原核表达[J].黑龙江畜牧兽医,2015(12):240-242.
-
5陈红波,张永峰,王一凡,王明松.干扰素联合利巴韦林治疗慢性丙型肝炎的疗效及不良反应观察[J].中外医学研究,2015,13(35):50-52. 被引量:6
-
6冯华,罗欣拉,杨帆.中医药治疗丙肝抗病毒不良反应的研究进展[J].湖北中医杂志,2016,38(5):69-71. 被引量:2
-
7陆晓梅,徐银,黄鹏,陈明珠,王洁,苏静,喻荣彬.干扰素-α治疗慢性丙型肝炎的疗效预测模型[J].实用临床医药杂志,2016,20(15):5-8. 被引量:2
-
8刘振宇,袁劲松,彭雁忠.国产派格宾治疗慢性乙型肝炎Ⅲ期临床试验严重不良事件观察[J].现代医药卫生,2016,32(17):2644-2646. 被引量:2
-
9程思,彭爽,陈皎皎,郭婷婷,胡陵静.中医外治为主治疗乳腺癌术后上肢水肿的思考与探索[J].中国中医急症,2016,25(10):1897-1899. 被引量:7
-
10刘树成.干扰素的分类与合理应用[J].北方药学,2016,13(11):152-153. 被引量:3
-
1杨立刚,陆正德.175例病毒性乙肝流行病学分析兼探乙肝传播途径[J].现代预防医学,1994,21(4):210-212. 被引量:2
-
2刘俊平,尚佳.别让干扰素不良反应成为您抗病毒治疗中的绊脚石[J].肝博士,2012(5):19-20.
-
3刘士敬.干扰素不良反应及防治[J].中国社区医师,2010,26(2):11-11. 被引量:7
-
4郭永丽,王昊,刘用璋.IL-1α对人甲状腺细胞NO的诱生作用及其细胞毒性[J].中华内分泌代谢杂志,2004,20(4):360-361.
-
5黄明政.中药治疗病毒性肝炎的研究进展[J].中国中医药咨讯,2011,3(9):252-252.
-
6王小坤,王运清.解毒化瘀方加减对乙型病毒性肝炎伴高胆红素血症肝纤维化及凝血功能的影响[J].四川中医,2016,34(8):116-119. 被引量:3
-
7刘晓琳.免疫接种后水痘病毒特异性SIgA的低诱生作用[J].生物制品快讯,2001(12):12-12.
-
8刘铁军.病毒性乙肝 防患于未然[J].家庭中医药,2010(2):40-43.
-
9陈桂芳.车务车辆职工抗-HBs阳性率的调查[J].现代预防医学,2002,29(5):684-684.
-
10肖晓梅,胡玉兰.病毒性乙肝母婴阻断的临床路经[J].中国社区医师(医学专业),2013,15(5):126-126. 被引量:1